Nursing Medication Card - Naloxone (Narcan)(Kor/Eng)

 

Narcan (Naloxone)

• 적응증: 아편류(마약) 과다복용 해독
• 작용 기전: 아편 수용체 길항 → 진정, 호흡 억제 반전
• 흡수와 대사: IV/IM/SC/비강 투여, 간 대사 후 신장 배설
• 부작용: 금단 증상 (불안, 고혈압, 통증), 오심, 구토
• 투여량: 0.4–2mg IV 반복 가능, 비강 4mg 1회
• 간호 고려사항: 환자 의식/호흡 모니터링, 재투여 필요 여부 확인, 금단 반응 주의

Narcan (Naloxone)

• 분류: 오피오이드 길항제
• 적응증: 아편류 과다복용 응급처치
• 부작용: 금단 증상(통증, 불안, 고혈압), 오심
• 간호 포인트: 효과 짧음(30–90분), 재투여 필요할 수 있음. 기도 유지 우선!

 

Naloxone (Narcan) 

Antidotes (for opioids) / opioid antagonists 

● Indications: reversal o fDNS depression and respiratory depression due to suspected opioid overdose ● Therapeutic effects: reversal of signs of opioid excess 

● Absorption: well after IM or SUBCUT. Rapidly from nasal mucosa 

● Distribution: rapid to tissues. Cross placenta 

● Metabolism&Excretion: by liver 

● Onset/Peak/Duration: IV: 1-2min onset, 45 min duration, IM/Subcut: 2-5min onset, >45min duration, Intranasal: 8-13min onset 

● ADE: CV: ventricular arrhythmias 

Naloxone (Narcan)

• Indications: Emergency treatment of known or suspected opioid overdose.
• Therapeutic Effects: Opioid receptor antagonist; reverses effects of opioids.
• Absorption: Effective via intravenous, intramuscular, subcutaneous, and intranasal routes.
• Distribution: Rapid distribution; crosses the placenta.
• Metabolism & Excretion: Hepatic metabolism; excreted in urine.
• Adverse Effects: Withdrawal symptoms in opioid-dependent individuals, hypertension, tachycardia.
• Dose: 0.4–2 mg IV/IM/subcutaneously every 2–3 minutes as needed; intranasal: 4 mg as a single dose.
• Considerations: Monitor respiratory and cardiovascular status; repeated dosing may be necessary due to shorter half-life compared to some opioids.RxListDrugBank+1RxList+1Drugs.com+1WebMD+1